Article citationsMore >>

Crooke ST. Vitravene-another piece in the mosaic. Antisense Nucleic Acid Drug Dev, 8:vii-viii1998

has been cited by the following article:

Article

Long Term Outcome of Intravitreal Therapy with Pegaptanib Sodium in an Infant with Active Retinitis due to Postnatally Acquired Cytomegalovirus Infection

1Department of Medical and Surgical Neonatology, Bambino Gesu’ Chldren’s Hospital (IRCCS) Rome, Italy

2Department of Ophtalmology, Bambino Gesu’ Chldren’s Hospital (IRCCS) Rome, Italy


American Journal of Medical Case Reports. 2015, Vol. 3 No. 7, 209-211
DOI: 10.12691/ajmcr-3-7-7
Copyright © 2015 Science and Education Publishing

Cite this paper:
Cinzia Auriti, Fiammetta Piersigilli, Gino Catena. Long Term Outcome of Intravitreal Therapy with Pegaptanib Sodium in an Infant with Active Retinitis due to Postnatally Acquired Cytomegalovirus Infection. American Journal of Medical Case Reports. 2015; 3(7):209-211. doi: 10.12691/ajmcr-3-7-7.

Correspondence to: Fiammetta  Piersigilli, Department of Medical and Surgical Neonatology, Bambino Gesu’ Chldren’s Hospital (IRCCS) Rome, Italy. Email: fiammetta.piersigilli@opbg.net

Abstract

We describe the case of an infant with a retinitis due to a postnatally acquired Cytomegalovirus, successfully treated at six months of life with three cycles of intravitreal injections of pegaptanib sodium. The therapy was effective in modulating the retinal disease activity in this immunocompetent child, without any side effect observed at a long-term follow up.

Keywords